跳到正文
原文
Regeneron· @Regeneron · X·· 2 小时前AI 评分42
AI 导读

我们很高兴地宣布,欧盟委员会(EC)已批准我们药物在皮肤癌、肺癌和宫颈癌现有获批适应症中的更新给药方案。了解更多:https://bit.ly/3Wy6I6x

正文

We are pleased to share that the European Commission (EC) has approved an updated dosing regimen for our medicine across its currently approved indications in skin, lung, and cervical cancers. Learn more: https://bit.ly/3Wy6I6x

来源:Regeneron · x.com